Last update March 30, 2014
Low Risk
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Nabumetone belongs to this group or family:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 35 | % |
Molecular weight | 228 | daltons |
Protein Binding | 99 | % |
Tmax | 2 - 8 | hours |
T½ | 25 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Latest update failed to find relevant data on breastfeeding.
Both a high molecular weight and high plasma protein-binding makes excretion into breast milk unlikely.
The infant is further protected because of a low oral bioavailability.
Until more information on this drug concerning breastfeeding is available, a safer alternative should be preferred.